BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.50. This compares to loss of $1.72 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 36%. A quarter ago, it was expected that this company would post a loss of $0.76 per share when it actually produced a loss of $0.21, delivering a surprise of 72.37%.Over the last four quarters, the company has ...